Home NDC 0002-4732 Olumiant
Product NDC 0002-4732
11-digit product format 000024732
Labeler code 0002
Product ID 0002-4732_ee836a23-8bb1-4e69-b93b-7ed3558e403d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name baricitinib
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Eli Lilly and Company
Application NDA207924
Marketing category NDA
Marketing start 2019-10-08
Substance BARICITINIB
Active strength 1 mg/1
Pharmacologic classes Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N207924-001 OLUMIANT BARICITINIB 2MG TABLET / ORAL AB RLD 2018-05-31 N207924-002 OLUMIANT BARICITINIB 1MG TABLET / ORAL AB RLD 2019-10-08 N207924-003 OLUMIANT BARICITINIB 4MG TABLET / ORAL AB RLD, RS 2022-05-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 17 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N207924-001 8420629 2029-03-10 U-247 2018-06-20 N207924-001 11806555 2031-11-02 U-3500 2023-11-21 N207924-001 9737469 2031-11-02 U-3500 2023-01-09 N207924-001 8158616 2032-05-31 Drug substance, Drug product 2018-06-20 N207924-001 11045474 2032-11-30 U-3372 2022-05-26 N207924-001 9089574 2032-11-30 U-3372 2022-05-26 N207924-002 8420629 2029-03-10 U-247 2020-10-26 N207924-002 11806555 2031-11-02 U-3500 2023-11-21 N207924-002 9737469 2031-11-02 U-3500 2023-01-09 N207924-002 8158616 2032-05-31 Drug substance, Drug product 2020-10-26 N207924-002 11045474 2032-11-30 U-3372 2022-05-26 N207924-002 9089574 2032-11-30 U-3372 2022-05-26 N207924-003 11806555 2031-11-02 U-3500 2023-11-21 N207924-003 9737469 2031-11-02 U-3500 2023-01-09 N207924-003 8158616 2032-05-31 Drug substance, Drug product 2022-05-26 N207924-003 11045474 2032-11-30 U-3372 2022-05-26 N207924-003 9089574 2032-11-30 U-3372 2022-05-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 118 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N207924-001 OLUMIANT 2MG TABLET / ORAL AB RLD 2018-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 OLUMIANT 1MG TABLET / ORAL AB RLD 2019-10-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-003 OLUMIANT 4MG TABLET / ORAL AB RLD, RS 2022-05-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 N207924-001 OLUMIANT 2MG TABLET / ORAL AB RLD 2018-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 OLUMIANT 1MG TABLET / ORAL AB RLD 2019-10-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-003 OLUMIANT 4MG TABLET / ORAL AB RLD, RS 2022-05-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 N207924-001 OLUMIANT 2MG TABLET / ORAL AB RLD 2018-05-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-002 OLUMIANT 1MG TABLET / ORAL AB RLD 2019-10-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-003 OLUMIANT 4MG TABLET / ORAL AB RLD, RS 2022-05-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N207924-001 OLUMIANT 2MG TABLET / ORAL AB RLD 2018-05-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N207924-002 OLUMIANT 1MG TABLET / ORAL AB RLD 2019-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N207924-003 OLUMIANT 4MG TABLET / ORAL AB RLD, RS 2022-05-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N207924-001 OLUMIANT 2MG TABLET / ORAL AB RLD 2018-05-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N207924-002 OLUMIANT 1MG TABLET / ORAL AB RLD 2019-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N207924-003 OLUMIANT 4MG TABLET / ORAL AB RLD, RS 2022-05-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N207924-001 OLUMIANT 2MG TABLET / ORAL RLD 2018-05-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N207924-002 OLUMIANT 1MG TABLET / ORAL RLD 2019-10-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N207924-003 OLUMIANT 4MG TABLET / ORAL RLD, RS 2022-05-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N207924-001 OLUMIANT 2MG TABLET / ORAL AB RLD 2018-05-31 79d66fd596c7…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 14 · 536 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N207924-001 8420629 2029-03-10 U-247 2018-06-20 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-001 11806555 2031-11-02 U-3500 2023-11-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-001 9737469 2031-11-02 U-3500 2023-01-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-001 8158616 2032-05-31 Drug substance, Drug product 2018-06-20 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-001 11045474 2032-11-30 U-3372 2022-05-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-001 9089574 2032-11-30 U-3372 2022-05-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 8420629 2029-03-10 U-247 2020-10-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 11806555 2031-11-02 U-3500 2023-11-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 9737469 2031-11-02 U-3500 2023-01-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 8158616 2032-05-31 Drug substance, Drug product 2020-10-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 11045474 2032-11-30 U-3372 2022-05-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-002 9089574 2032-11-30 U-3372 2022-05-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-003 11806555 2031-11-02 U-3500 2023-11-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-003 9737469 2031-11-02 U-3500 2023-01-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-003 8158616 2032-05-31 Drug substance, Drug product 2022-05-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-003 11045474 2032-11-30 U-3372 2022-05-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207924-003 9089574 2032-11-30 U-3372 2022-05-26 c2088c7a36db…2026-09-14 22:38:34 2026-08 N207924-001 8420629 2029-03-10 U-247 2018-06-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-001 11806555 2031-11-02 U-3500 2023-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-001 9737469 2031-11-02 U-3500 2023-01-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-001 8158616 2032-05-31 Drug substance, Drug product 2018-06-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-001 11045474 2032-11-30 U-3372 2022-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-001 9089574 2032-11-30 U-3372 2022-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 8420629 2029-03-10 U-247 2020-10-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 11806555 2031-11-02 U-3500 2023-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 9737469 2031-11-02 U-3500 2023-01-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 8158616 2032-05-31 Drug substance, Drug product 2020-10-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 11045474 2032-11-30 U-3372 2022-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-002 9089574 2032-11-30 U-3372 2022-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-003 11806555 2031-11-02 U-3500 2023-11-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-003 9737469 2031-11-02 U-3500 2023-01-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-003 8158616 2032-05-31 Drug substance, Drug product 2022-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-003 11045474 2032-11-30 U-3372 2022-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207924-003 9089574 2032-11-30 U-3372 2022-05-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N207924-001 8420629 2029-03-10 U-247 2018-06-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-001 11806555 2031-11-02 U-3500 2023-11-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-001 9737469 2031-11-02 U-3500 2023-01-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-001 8158616 2032-05-31 Drug substance, Drug product 2018-06-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-001 11045474 2032-11-30 U-3372 2022-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207924-001 9089574 2032-11-30 U-3372 2022-05-26 caaa826d4ba7…
Observed Orange Book exclusivity history# Exclusivity history page 2 of 6 · 208 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Olumiant
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BARICITINIB 1 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0002-4732-30 Olumiant 30 in 1 BOTTLE TABLET, FILM COATED 30 28
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0002-4732 OLUMIANT (BARICITINIB) TABLET, FILM COATED [ELI LILLY AND COMPANY] 23 Current NDC, Legacy NDC, 1 package rows 20241206_866e9f35-9035-4581-a4b1-75a621ab55cf.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0002-4732-30 00002473230 30 TABLET, FILM COATED in 1 BOTTLE (0002-4732-30) 2019-10-08 0000-00-00 No No Current